Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly.
Klein KC
,
Polyak SJ
,
Lingappa JR
.
???displayArticle.abstract???
The assembly of hepatitis C virus (HCV) is poorly understood, largely due to the lack of mammalian cell culture systems that are easily manipulated and produce high titers of virus. This problem is highlighted by the inability of the recently established HCV replicon systems to support HCV capsid assembly despite high levels of structural protein synthesis. Here we demonstrate that up to 80% of HCV core protein synthesized de novo in cell-free systems containing rabbit reticulocyte lysate or wheat germ extracts assembles into HCV capsids. This contrasts with standard primate cell culture systems, in which almost no core assembles into capsids. Cell-free HCV capsids, which have a sedimentation value of approximately 100S, have a buoyant density (1.28 g/ml) on cesium chloride similar to that of HCV capsids from other systems. Capsids produced in cell-free systems are also indistinguishable from capsids isolated from HCV-infected patient serum when analyzed by transmission electron microscopy. Using these cell-free systems, we show that HCV capsid assembly is independent of signal sequence cleavage, is dependent on the N terminus but not the C terminus of HCV core, proceeds at very low nascent chain concentrations, is independent of intact membrane surfaces, and is partially inhibited by cultured liver cell lysates. By allowing reproducible and quantitative assessment of viral and cellular requirements for capsid formation, these cell-free systems make a mechanistic dissection of HCV capsid assembly possible.
Aizaki,
Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor.
2003, Pubmed
Aizaki,
Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor.
2003,
Pubmed
Ali,
Cell-free replication of the hepatitis C virus subgenomic replicon.
2002,
Pubmed
Bartenschlager,
Novel cell culture systems for the hepatitis C virus.
2001,
Pubmed
Bartenschlager,
Replication of hepatitis C virus.
2000,
Pubmed
Baumert,
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells.
1998,
Pubmed
Baumert,
Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate.
1999,
Pubmed
Blanchard,
Hepatitis C virus-like particle budding: role of the core protein and importance of its Asp111.
2003,
Pubmed
Blanchard,
Hepatitis C virus-like particle morphogenesis.
2002,
Pubmed
Blight,
Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.
2002,
Pubmed
Blight,
Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture.
2003,
Pubmed
Blight,
Efficient initiation of HCV RNA replication in cell culture.
2000,
Pubmed
Blobel,
Unidirectional and bidirectional protein traffic across membranes.
1995,
Pubmed
Bose,
Rapid regulation of steroidogenesis by mitochondrial protein import.
2002,
Pubmed
Dooher,
Conservation of a stepwise, energy-sensitive pathway involving HP68 for assembly of primate lentivirus capsids in cells.
2004,
Pubmed
Erickson,
Cell-free translation of messenger RNA in a wheat germ system.
1983,
Pubmed
Ezelle,
Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector.
2002,
Pubmed
Falcón,
Ultrastructural evidences of HCV infection in hepatocytes of chronically HCV-infected patients.
2003,
Pubmed
Gale,
Molecular clones of hepatitis C virus: applications to animal models.
2001,
Pubmed
Hardy,
Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells.
2003,
Pubmed
Hegde,
Sequence-specific alteration of the ribosome-membrane junction exposes nascent secretory proteins to the cytosol.
1996,
Pubmed
Hegde,
Regulation of protein topology by trans-acting factors at the endoplasmic reticulum.
1998,
Pubmed
Hope,
The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins.
2002,
Pubmed
Hu,
Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase.
1996,
Pubmed
Hu,
Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids.
1997,
Pubmed
Hu,
Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection.
2001,
Pubmed
Ikeda,
Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.
2002,
Pubmed
Kaito,
Hepatitis C virus particle detected by immunoelectron microscopic study.
1994,
Pubmed
Kanto,
Buoyant density of hepatitis C virus recovered from infected hosts: two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation.
1994,
Pubmed
Kato,
Processing of hepatitis C virus core protein is regulated by its C-terminal sequence.
2003,
Pubmed
Kunkel,
Conformational changes accompanying self-assembly of the hepatitis C virus core protein.
2002,
Pubmed
Kunkel,
Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein.
2001,
Pubmed
Lai,
In vitro RNA replication directed by replicase complexes isolated from the subgenomic replicon cells of hepatitis C virus.
2003,
Pubmed
Le,
Identification of two RNA-binding proteins associated with human telomerase RNA.
2000,
Pubmed
Lindsay,
Introduction to therapy of hepatitis C.
2002,
Pubmed
Lingappa,
A eukaryotic cytosolic chaperonin is associated with a high molecular weight intermediate in the assembly of hepatitis B virus capsid, a multimeric particle.
1994,
Pubmed
Lingappa,
A multistep, ATP-dependent pathway for assembly of human immunodeficiency virus capsids in a cell-free system.
1997,
Pubmed
,
Xenbase
Liu,
Regulated processing of hepatitis C virus core protein is linked to subcellular localization.
1997,
Pubmed
Lo,
Interaction between hepatitis C virus core protein and E1 envelope protein.
1996,
Pubmed
Lohmann,
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.
1999,
Pubmed
Lohmann,
Mutations in hepatitis C virus RNAs conferring cell culture adaptation.
2001,
Pubmed
Lorenzo,
Assembly of truncated HCV core antigen into virus-like particles in Escherichia coli.
2001,
Pubmed
Maillard,
Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients.
2001,
Pubmed
McLauchlan,
Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets.
2002,
Pubmed
McLauchlan,
Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes.
2000,
Pubmed
Melton,
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.
1984,
Pubmed
Miyamoto,
Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction.
1992,
Pubmed
Mizuno,
Virion-like structures in HeLa G cells transfected with the full-length sequence of the hepatitis C virus genome.
1995,
Pubmed
Molla,
Cell-free, de novo synthesis of poliovirus.
1991,
Pubmed
Moriishi,
Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein.
2003,
Pubmed
Perara,
A former amino terminal signal sequence engineered to an internal location directs translocation of both flanking protein domains.
1985,
Pubmed
Pietschmann,
Persistent and transient replication of full-length hepatitis C virus genomes in cell culture.
2002,
Pubmed
Poynard,
Natural history of HCV infection.
2000,
Pubmed
Sakalian,
Separate assembly and transport domains within the Gag precursor of Mason-Pfizer monkey virus.
1999,
Pubmed
Sakalian,
Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro.
1996,
Pubmed
Sakalian,
Molecular events in the assembly of retrovirus particles.
1998,
Pubmed
Santolini,
Biosynthesis and biochemical properties of the hepatitis C virus core protein.
1994,
Pubmed
Shimizu,
Hepatitis C virus: detection of intracellular virus particles by electron microscopy.
1996,
Pubmed
Suzuki,
Ubiquitin-mediated degradation of hepatitis C virus core protein is regulated by processing at its carboxyl terminus.
2001,
Pubmed
Walter,
Purification of a membrane-associated protein complex required for protein translocation across the endoplasmic reticulum.
1980,
Pubmed
Walter,
Translocation of proteins across the endoplasmic reticulum. II. Signal recognition protein (SRP) mediates the selective binding to microsomal membranes of in-vitro-assembled polysomes synthesizing secretory protein.
1981,
Pubmed
Walter,
Translocation of proteins across the endoplasmic reticulum III. Signal recognition protein (SRP) causes signal sequence-dependent and site-specific arrest of chain elongation that is released by microsomal membranes.
1981,
Pubmed
Walter,
Preparation of microsomal membranes for cotranslational protein translocation.
1983,
Pubmed
Weldon,
Type D retrovirus capsid assembly and release are active events requiring ATP.
1998,
Pubmed
Yasui,
The native form and maturation process of hepatitis C virus core protein.
1998,
Pubmed
Zimmerman,
Identification of a host protein essential for assembly of immature HIV-1 capsids.
2002,
Pubmed
